Head-to-head · Value Score
CoreAge Rx vs NEUVÉ Health
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, NEUVÉ Health a 75. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameNEUVÉ Health
#141 · Grade C+ · Fair Price
Est. first month
$170/mo (injectable standard dose compounded with glycine; $217/mo with B12)
Save ~87% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 75 — an est. $99/mo first month, with no teaser step-up baked in. NEUVÉ Health isn't out of it: Shoppers who want to compare an injectable against a daily sublingual at the same desk, and who will get the question of what is included answered in writing first.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | NEUVÉ Health |
|---|---|---|
| Value Score | 93 (A+) | 75 (C+) |
| Est. first month | $99/mo | $170/mo (injectable standard dose compounded with glycine; $217/mo with B12) |
| Save vs brand-name | ~89% | ~87% |
| Semaglutide | $99/mo | $170/mo (injectable standard dose compounded with glycine; $217/mo with B12) |
| Tirzepatide | $149/mo | $324/mo (injectable standard dose; $282/mo as a daily sublingual) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states claimed, with members in 40+ |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
NEUVÉ Health
Twelve GLP-1 prices published one per product with no plan ladder and no introductory month — sold under a heading promising all-in monthly pricing that the same page's fine print contradicts.
Why it's a deal
- Twelve GLP-1 prices are published before any intake, one per product rather than as a range: $170 and $217 for standard semaglutide depending on the compounding, $324 for standard tirzepatide, and $138 to $160 for the daily sublingual low-dose products
- There is no introductory month, no prepay ladder and no commitment tier on the site at all, so the advertised figure is the recurring figure — the trap this site exists to catch is absent
- The compounding is disclosed per product: whether the injection is prepared with B12 or with glycine is on the card, which lets a buyer with a B12 preference choose on a fact rather than an assumption
- Both routes are covered at full dose and low dose, so the daily sublingual and the weekly injection can be compared at the same desk on published numbers
- The pharmacy class is now stated — compounded by a 503A pharmacy, with fulfilment through 503A or 503B facilities — which is more than most desks in this batch put in writing
- Cancellation is stated once and plainly: cancel at any time, future charges stop, past periods are not refunded
The fine print
- The site gives three different answers to whether the medication is inside the price. The weight-loss page is headed "all-in monthly pricing" and its own fine print says medication, labs and treatment supplies are billed separately — and the clinical partner that would settle it is not named
- Three membership tiers are named once, in the financial policy, and priced nowhere on the site
- Four different starting floors are advertised across the site, and the lowest belongs to a different treatment line entirely, so the cheapest number a shopper meets is not a weight-loss price
- Every legal page — terms, privacy, refund and financial — ends by saying it is plain-English summary copy being reviewed by counsel and subject to change before public launch, on a site that is live and taking payment
- The homepage claims all fifty states and, on the same page, members in more than forty, without the distinction the about page draws; the financial policy narrows it further to an Arizona-licensed clinician
- No compounding pharmacy is named, no medical group is named and no clinician identifier is published — the only named people are a founder and one practitioner seen once in the signup
- No phone number is published anywhere on the site, and the support address sits on a different domain from the one selling the treatment
- One low-dose product card's inclusion list names the wrong molecule, which on a prescription product is not a typographical matter
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to NEUVÉ Health.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.